People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Biotech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acoustic Wave Cell Therapy, Inc. | — | Biotech | Series A | $20.5M | $85.0M | 2016 |
| RevolutionCredit, Inc. | — | Other Technology | Series A | $15.9M | $19.7M | 2019 |
PAUL MACCASKILL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PAUL MACCASKILL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Schwartz | 1 | 7 |
| Larry Rosenberger | 1 | 3 |
| Michael Heller | 1 | 2 |
| Zaydoon H. Munir | 1 | 1 |
| Paul H. Breloff | 1 | 1 |
| Larry H. Rosenberger | 1 | 1 |
| Edward H. Ojdana | 1 | 1 |
| CHARLES ENGLES | 1 | 1 |
| TOM LUE | 1 | 1 |
| CHIAHUI WANG | 1 | 1 |
| Laura H. Conrad | 1 | 1 |
| Edward Ojdana | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.